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Abstract
Background: Mast cells were associated with intestinal ischemia-reperfusion injury, the study was
to observe the influence of Ketotifen, Cromolyn Sdium(CS), and Compound 48/80(CP) on the
survival rates on the third day after intestinal ischemia-reperfusion injury in rats.
Methods: 120 healthy Sprague-Dawley rats were randomly divided into 5 groups, Sham-operated
group (group S), model group (group M), group K, group C and group CP. Intestinal damage was
triggered by clamping the superior mesenteric artery for 75 minutes, group K, C, and CP were
treated with kotifen 1 mg·kg-1, CS 50 mg·kg-1, and CP 0.75 mg·kg-1 i.v. at 5 min before reperfusion
and once daily for three days following reperfusion respectively. Survival rate in each group was
recorded during the three days after reperfusion. All the surviving rats were killed for determining
the concentration of serum glutamic-oxaloacetic transaminase(AST), glutamic pyruvic
transaminase(ALT), the ratio of AST compare ALT(S/L), total protein(TP), albumin(ALB),
globulin(GLB), the ratio of ALB compare GLB(A/G), phosphocreatine kinase(CK), lactate
dehydrogenase(LDH), urea nitrogen(BUN) and creatinine(CRE) at the 3rd day after reperfusion.
And ultrastructure of IMMC, Chiu's score, lung histology, IMMC counts, the levels of TNF-α, IL-
1β, IL-6 and IL-10 of the small intestine were detected at the same time.
Results: Intestinal ischemia-reperfusion injury reduced the survival rate. The concentrations of TP,
ALB and level of IL-10 in intestine in group M decreased significantly while the concentrations of S/
L, LDH and the levels of IL-6 and TNF-α in intestine increased significantly compared with group S
(P < 0.05). Treatment with Ketotifen and CS increased the survival rate compared with group M
(P  < 0.05), attenuated the down-regulation or up-regulation of the above index (P  < 0.05).
Treatment with CP decreased the survival rate on the 3rd day after reperfusion compared with
group M(P < 0.05). Group K and C had better morphology in IMMC in the small intestine and in
the lungs than in group M and CP, although the Chiu's score and IMMC counts remained the same
in the five groups(P > 0.05).
Conclusion: Mast cell inhibition after ischemia prior to reperfusion and following reperfusion may
decrease the multi-organ injury induced by intestine ischemia reperfusion, and increase the survival
rates.
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Background
Intestinal ischemia-reperfusion injury (IIRI) contributes
to the pathophysiology of many conditions, including
abdominal aortic aneurysm surgery, small bowel trans-
plantation, cardiopulmonary bypass, strangulated her-
nias, and neonatal necrotizing enterocolitis [1,2]. In
addition to localized tissue damages, IIRI induces inflam-
matory damages in remote organs, particularly in the lung
and liver, and is associated with a high mortality [3].
Intestinal mucosal mast cells (IMMC) are particularly fre-
quent in close proximity to epithelial surfaces, where they
are strategically located for optimal interaction with the
environment and for their putative functions for host
defense [4]. Previous studies demonstrated that the de-
granulation of IMMC can be induced by oxidants gener-
ated in the post-ischemic gut, and the released inflamma-
tory mediators such as histamine and tumor necrosis
factor-α(TNF-α) could aggravate the injury to intestine
after reperfusion [5,6].
Cordeiro and colleagues reported that administration of
diphenhydramine (50 mg/kg, H2 blocker) before reper-
fusion can significantly reduce the extent of flap necrosis
and the neutrophil and mast cell counts caused by
ischemia/reperfusion [7]. Kalia found that all ketotifen-
pretreated animals (1 mg/kg orally twice a day for 3 days
before ischemia) survived in 12 hours after ischemia-
reperfusion(I/R), while the ten untreated animals sub-
jected to intestinal I/R failed to survive the reperfusion
period (Each group had 12 animals) [8]. The above results
prove that administration of antihistaminic agents could
decrease IIRI.
The influence of administration of mast cell membrane
stabilizer, H2 blocker or mast cell degranulator on the
damage and the survival rate caused by IIRI after intestinal
ischemia have not previously been well investigated. The
purpose of our present investigation was to observe the
influence of Ketotifen, cromolyn sodium, and compound
48/80 on the survival after intestinal ischemia-reperfusion
injury in rats, and provided a new therapeutic method to
treat IIRI.
Methods
Establish the small intestinal ischemia-reperfusion injury 
model in rats and the experimental design
This study proceeded after being reviewed and approved
by the Institutional Animal Care and Use Committee in
accordance with the ethical principles provided by the
Experimental Animal Laboratory of School of Medicine,
SUN Yat-sen University. Forty-eight healthy Sprague-
Dawley rats (weighing 200–250 g) were randomly
divided into four groups. Each of which contained 12 rats,
the group I (the ischemia time was 60 min), group II (the
ischemia time was 75 min), group III (the ischemia time
was 90 min), and group IV (the ischemia time was 120
min). Laboratory temperature was kept at 25–27°C. Sur-
gery was conducted under general anesthesia with intra-
peritoneal sodium pentobarbital (45 mg/kg) after they
had been fasted for 18 h. The rats' abdomens were opened
and their superior mesenteric artery (SMA) were found
and clamped for 60, 75, 90 and 120 min respectively.
Then the clamp was released and abdominal membrane,
muscle and skin were sutured gradually. In addition, 5%
Cefoperazone was injected intra-peritoneal to avoid
wound infection. Animals were housed individually in
wire-bottomed cages, free to eat water and food. The sur-
vival rates in each group were observed during the 1st day
to the 7th day after intestine ischemia/reperfusion.
Based on the above result, One hundred and twenty
healthy Sprague-Dawley rats (200–250 g) were randomly
divided into five groups. Each of which contained 24 rats,
Sham-operated group(group S), model group(group M),
Ketotifen treated group(group K), cromolyn sodium
treated group(group C) and compound 48/80 treated
group(group CP). Intestinal damages were induced by
clamping the superior mesenteric artery for 75 minutes
based on the above study. Group K, C, and CP were
treated with ketotifen (Sigma; USA) 1 mg·kg-1, CS (ICN;
USA)50 mg·kg-1, and CP (Sigma; USA) 0.75 mg·kg-1 via
caudal vein at 5 min before reperfusion, respectively,
while group S and M were treated with the same volume
of saline. Then the clamp was released and abdominal
membrane, muscle and skin were sutured gradually. In
addition, 5% Cefoperazone was injected intra-peritoneal
to avoid wound infection. Animals were housed individ-
ually in wire-bottomed cages, free to eat water and food.
The surviving rats in group K, C, and CP were treated with
ketotifen 1 mg·kg-1, CS 50 mg·kg-1, and CP 0.75 mg·kg-
1 via caudal vein once daily for 3 days after reperfusion
respectively, while group S and M were treated with the
same volume saline.
Survival rates
The survival rates in each group were observed during the
1st day to the 3rd day after intestine ischemia/reperfusion.
The state, action, drinking and eating of each surviving rat
was also recorded.
Preparation of specimens and measurements
The surviving rats were sacrificed by anesthetic overdose.
8 rats in each group except only 3 rats in group CP were
paunched rapidly on the 3rd day after reperfusion. 2 mL
blood was obtained from the inferior vena cava, frozen at
-20°C for 5 minutes and centrifuged for 15 minutes at
4,000 r/min. Supernatants were transferred into fresh
tubes for evaluation of concentration of glutamic-
oxaloacetic transaminase (AST), glutamic pyruvicBMC Gastroenterology 2008, 8:42 http://www.biomedcentral.com/1471-230X/8/42
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transaminase (ALT), the ratio of AST compare ALT (S/L),
total protein (TP), albumin (ALB), globulin (GLB), the
ratio of ALB compare GLB (A/G), phosphocreatine kinase
(CK), lactate dehydrogenase (LDH), urea nitrogen (BUN)
and creatinine (CRE) through automatic biochemistry
analyzer(abbott, USA).
Intestine histology
A 0.5–1.0 cm intestinal segment was cut 5 cm from the
terminal ileum and fixed in 4% formaldehydum polymer-
isatum, then embedded in paraffin for sectioning. The
segment was then stained with hematoxylin-eosin. Dam-
ages of intestinal mucosa were evaluated by two different
histopathologist according to the criteria of Chiu's
method [9]. Criteria of Chiu grading system consists of 5
subdivisions according to the changes of villus and gland
of intestinal mucosa: grade 0, normal mucosa; grade 1,
development of subepithelial Gruenhagen's space at the
tip of villus; grade 2, extension of the space with moderate
epithelial lifting; grade 3, massive epithelial lifting with a
few denuded villi; grade 4, denuded villi with exposed
capillaries; and grade 5, disintegration of the lamina pro-
pria, ulceration and hemorrhage.
Transmission Electron Microscopy
Another 0.5 cm intestinal segment cut 5 cm from the ter-
minal ileum were immersed and fixed in 2.5% glutaralde-
hyde overnight at 4°C and washed three times in PBS.
They were then postfixed in aqueous 1% OsO4 and 1%
K3Fe (CN)6 for 1 hour. Following three times of PBS wash-
ing, the tissue was dehydrated through a graded series of
30 to 100% ethanol and 100% propylene oxide and
immersed in 1:1 mixture of propylene oxide and Polybed
812 epoxy resin for 1 hour. The infiltration solution was
then changed to 100% resin. After 24 hours of infiltration,
the tissue was embedded in molds and cured at 37°C
overnight, followed by additional hardening at 65°C for
2 days. Ultrathin (70 nm) sections were collected on 200-
mesh copper grids and stained with 2% uranyl acetate in
50% methanol for 10 minutes, followed by 1% lead cit-
rate for 7 minutes. Sections were photographed using a
Hitachi H-600 transmission electron microscope
(TOSHIBA, Japan) at 80 kV onto electron microscope
film.
Lung histology
A median sternotomy was performed. The harvested right
middle lobe of the lung was fixed in 4% formaldehydum
polymerisatum. Paraffin-embedded sections (5 μm) were
stained with hematoxylin-eosin and evaluated blindly by
two different histopathologist.
Detection of concentration of protein in intestine
Another segment of 10 cm intestine was cut 5 cm from ter-
minal ileum. The small intestine was washed with frozen
saline and dried with suction paper at 4°C. Intestinal tis-
sues were homogenized with normal saline. Intestinal
protein (content) was quantified by the Bradford method
with a BSA standard kit, provided by Shenerg Biocolor
BioScience & Technolgy Company, Shanghai, China.
Detection of the levels of TNF-α, IL-1β, IL-6 and IL-10 in 
the intestine
Intestinal tissues were homogenized with normal saline,
frozen at -20°C for 5 minutes and centrifuged for 15 min-
utes at 4,000 r/min. Supernatants were transferred into
fresh tubes. The levels of TNF-α, IL-1β, IL-6 and IL-10 were
measured using a bead-based immunofluorescence assay
(Luminex Inc. Austin, TX, USA)using multiplex cytokine
reagents supplied by Linco International, USA. Briefly,
antibody-coupled beads were incubated with the samples
(antigen), followed by incubation with biotinylated
detection antibody and streptavidin-phycoerythrin,
respectively. A broad sensitivity range of standards (Linco
International), ranging between 1.95 and 32 000 pg/ml
were used to help enable the quantization of a dynamic
wide range of cytokine concentrations and provide the
greatest sensitivity. This captured bead-complexes were
then read by the Luminex fluorescent bead-based technol-
ogy Luminex™ 200 Liquid Array (Luminex Corporation
Austin, TX, USA) with a flow-based dual laser detector
with real-time digital signal processing to facilitate the
analysis of up to 100 different families of colour-coded
polystyrene beads and allow multiple measurements of
the sample ensuring in the effective quantification of
cytokines. The levels of TNF-α, IL-1β, IL-6 and IL-10 in the
intestine were indicated as picogram per milligram of pro-
tein.
Immunohistochemical detection of tryptase in intestine
Five-micron-thick sections were prepared from paraffin-
embedded intestinal tissues. After deparaffinization,
endogenous peroxidase was quenched with 3% H2O2 in
deionised water for 10 minutes. Nonspecific binding sites
were blocked by incubating the sections in 10% normal
rabbit serum for 1 hour. The sections were then incubated
with polyclonal rat anti-mast cell tryptase (dilution 1: 50)
for 30 minutes at 37°C, followed by incubating with
biotinylated goat-anti-rat IgG at room temperature for
10–15 minutes. After 3 times rinsing of the sample with
PBS for 5 minutes, the horseradish-peroxidase-conjugated
streptavidin solution was added and incubated at room
temperature for 10–15 minutes. The antibody binding
sites were visualized by incubating with diaminobenzi-
dine-H2O2 solution. Sections incubated with PBS instead
of the primary antibody were used as negative controls.
Brownish granules in the cytoplasm were recognized as
positive staining for tryptase. We calculated the tryptase
positive mast cells in 5 representative areas at 400× mag-
nification by Image-Pro Plus 5.0 (USA)BMC Gastroenterology 2008, 8:42 http://www.biomedcentral.com/1471-230X/8/42
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Statistics
Data were expressed as mean ± SD. Analysis of variance
was performed using SPSS 11.0 software. One-way analy-
sis of variance was used for multiple comparison. Bonfer-
roni test was used for intra-group comparison or
Tamhane's T2 test was used if equal variances was not
assumed. Chi-Square test was used to determine the sig-
nificance of differences of the survival rates. Differences
were considered significant when P value was less than
0.05.
Results
Changes of survival rate after different ischemia time
The 1st to 7th day's survival rates after 60 minutes' intestine
ischemia were from 83.3% to 75%. The 1st to the 7th day's
survival rates after 75 minutes' intestine ischemia were
from 50% to 41.6%. The 1st to 7th day's survival rates after
90 minutes' intestine ischemia were from 33.3% to
16.7%, while the 1st to 7th day's survival rates after 120
minutes' intestine ischemia were from 16.7% to zero. The
survival rates on the 3rd day groups I, II, III and group IV
were 83.3%, 41.6%, 25%, and 0, respectively. There were
almost no animals died in the 4th to the 7th day after reper-
fusion. (Fig. 1)
Changes in survival rates and states after operation
The surviving rats in group S recovered more vigorously
and vitally on the 3rd day after 75 min intestine ischemia.
The survival states of the rats in group M, K and C also
recovered vigorously and vitally while those in group CP
recovered less vigorously and vitally.
The survival rates in group S were higher than those in the
ischemia-reperfusion groups, and the 3rd day's survival
rates in group M were lower than those in group K and C
while they were higher than those in group CP (P < 0.05),
there was no significant difference between group K and
group C(P  > 0.05). [3rd  day's survival rates: group S
92%(22/24), group M 42%(10/24), group K 75%(18/
24), group C 75%(18/24), group CP 12.5%(3/24)] (Fig.
2)
Changes of serum biochemical indicator in the survival rats
Compared with those on the 3rd day in group S, the con-
centrations of TP and ALB in group M decreased signifi-
cantly while S/L and LDH increased significantly (P  <
0.05) (Table 1); the concentrations of TP and ALB in
group K decreased significantly while S/L, CK, and LDH
increased significantly(P < 0.05) (Table 1); the concentra-
tions of TP, ALB and GLB in group C decreased signifi-
cantly while S/L and LDH increased significantly (P  <
0.05) (Table 1); the concentrations of TP, ALB and GLB in
group CP decreased significantly while AST, S/L and CK
increased significantly (P < 0.05) (Table 1).
The concentration of AST in group CP was higher than
that in group M, K, and C(P < 0.05) (Table 1); and the
concentration of CRE in group CP was higher than that in
group M (P < 0.05) (Table 1).
There were no significant differences in group M, C and
group K (P > 0.05). (Table 1)
Changes of levels of TNF-α, IL-1β, IL-6 and IL-10 in 
intestine in the survival rats
Compared with group S in the 3rd day, the level of IL-10 in
group M decreased significantly while IL-6 and TNF-α
Changes in survival rate after ischemia and reperfusion injury  (establish animal model) Figure 1
Changes in survival rate after ischemia and reper-
fusion injury (establish animal model). Group I (60 min-
utes of ischemia), group II (75 minutes of ischemia), group III 
(90 minutes of ischemia), and group IV (120 mins minute of 
ischemia).
Changes in the survival rate following 75 min intestine  ischemia Figure 2
Changes in the survival rate following 75 min intes-
tine ischemia. Compared with group S: *P < 0.05,**P < 
0.01; compared with group M: #P < 0.05, ##P < 0.01; com-
pared with group K: ΔP < 0.05, ΔΔP < 0.01; compared with 
group C: hP < 0.05, hhP < 0.01.BMC Gastroenterology 2008, 8:42 http://www.biomedcentral.com/1471-230X/8/42
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increased significantly (P < 0.05) (Table 2); the level of IL-
10 in group C decreased significantly (P < 0.05) (Table 2).
There were no significant differences in group K and CP
compared with group S(P > 0.05). (Table 2)
Compared with group M, the levels of IL-6 and TNF-α in
group K decreased significantly (P < 0.05). (Table 2)
There were no significant differences between group K and
group C(P > 0.05). (Table 2)
Changes of intestinal mucosa under light microscope and 
Chiu's score in the survival rats
The villus and glands were normal. No inflammatory cell
infiltration was observed in mucosal epithelial layer in
sham group. Slight edema of mucosa villus and infiltra-
tion of few necrotic epithelial inflammatory cells neu-
trophil leukomonocyte were found in mucosa epithelial
layer in M, K, C and CP groups. (Fig 3)
There were no significant differences in Chiu's score
among the five groups on the 3rd day (P > 0.05). (Table 2)
Changes of counts of IMMC and ultrastructure in the 
survival rats
There were no significant difference in the number of
IMMC among the five groups in the survival rats(P > 0.05)
(Fig. 4, Table 2). The ultrastructure of IMMC was normal
in the sham group. There were abundant vacuoles with
reduced number of granules in their endochylema in
groups M and CP. There were fewer swollen granules in
IMMC homogeneity in groups C and K (Fig. 5).
Changes of lung histology in the survival rats
The lung histological structure was normal in group S,
while the lung tissues were obviously damaged with
edema, hemorrhage, and inflammatory cell infiltration in
groups M and CP, and the injury was ameliorated in
groups C and K. (Fig 6)
Discussion
IIRI is a significant problem in small bowel transplanta-
tion, abdominal aortic aneurysm surgery, cardiopulmo-
nary bypass, strangulated hernias, and neonatal
necrotizing enterocolitis [10]. Most reports about IIRI
selected rats as the animal models. Differences in intesti-
nal ischemia time would result in different survival rates
after ischemia reperfusion. The ideal survival rate in intes-
tinal ischemia-reperfusion injury animal model should be
40%~50% after seven days as those survival could provide
an ideal model for treatment or study. Our study found
that with the prolonged intestinal ischemia time, the sur-
vival rate after ischemia reperfusion decreased signifi-
cantly. The survival rates after intestinal ischemia for 75
min were about 40%~50% during the 1st to 7th day after
reperfusion in Sprague-Dawley rats. In addition, we
observed most animals died on the 1st day after reper-
fusion, and there were almost no animals died on the 4th
to 7th day after reperfusion. As a result, the ischemia time
Table 1: changes of serum biochemical indicator (mean ± SD)




LDH (U/L) CK (U/L)
S 8 82 ± 21 56 ± 30 1.6 ± 0.4 71 ± 4 32 ± 3 38 ± 3 0.9 ± 0.1 6.0 ± 1.1 33 ± 3 69 ± 23 126 ± 29
M 8 121 ± 27 37 ± 7 3.4 ± 1.4** 60 ± 9* 24 ± 2** 36 ± 8 0.7 ± 0.1 6.0 ± 0.9 25 ± 3 235 ± 92* 205 ± 104
K 8 118 ± 47 40 ± 12 2.9 ± 0.6* 59 ± 3* 24 ± 2** 35 ± 3 0.7 ± 0.1 5.1 ± 1.0 28 ± 4 160 ± 60* 338 ± 
114**
C 8 114 ± 39 40 ± 12 2.9 ± 0.5* 55 ± 6** 24 ± 1** 31 ± 5* 0.8 ± 0.1 4.3 ± 
0.9**##
28 ± 3 138 ± 
34**
251 ± 147
CP 3 301 ± 
91**##ΔΔhh
45 ± 19 4.6 ± 
0.9**Δ
50 ± 12** 22 ± 5** 28 ± 8* 0.8 ± 0.1 5.3 ± 0.7 34 ± 6# 343 ± 61 41 ± 
149**
Compared with group S:*P < 0.05, **P < 0.01; compared with group M: #P < 0.05, ##P < 0.01; compared with group K: ΔP < 0.05, ΔΔP < 0.01; 
compared with group C: hP < 0.05, hhP < 0.01.
Table 2: Changes of the levels of TNF-α, IL-1β, IL-6, IL-10, IMMC counts and Chiu's score in the intestine(mean ± SD)
n IL-10 (pg/mg) IL-1β (pg/mg) IL-6 (pg/mg) TNF-α (pg/mg) IMMC counts (n/field) Chiu's score
S 8 33 ± 4 613 ± 194 6 ± 2 30 ± 11 24 ± 14 0.4 ± 0.5
M 8 21 ± 5** 657 ± 129 40 ± 16** 43 ± 5* 26 ± 11 1.0 ± 0.5
K 8 27 ± 3 750 ± 150 13 ± 5# 27 ± 7## 28 ± 13 0.6 ± 0.6
C 8 22 ± 5** 678 ± 170 29 ± 12**h 25 ± 8## 31 ± 12 1.0 ± 0.5
CP 3 34 ± 3 814 ± 234 28 ± 5 33 ± 5 29 ± 7 1.0 ± 1.0
Compared with group S:*P < 0.05, **P < 0.01; compared with group M: #P < 0.05, ##P < 0.01; compared with group K: ΔP < 0.05, ΔΔP < 0.01; 
compared with group C: hP < 0.05, hhP < 0.01.BMC Gastroenterology 2008, 8:42 http://www.biomedcentral.com/1471-230X/8/42
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Microscopic appearance after hematoxylin and eosin staining (× 200) Figure 3
Microscopic appearance after hematoxylin and eosin staining (× 200). The villus and glands were normal and no 
inflammatory cell infiltration was observed in mucosal epithelial layer in sham group. Light edema of mucosa villus and infiltra-
tion of few necrotic epithelial inflammatory cells neutrophil leukomonocyte were found in mucosa epithelial layer in M, K, C 
and CP groups.BMC Gastroenterology 2008, 8:42 http://www.biomedcentral.com/1471-230X/8/42
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Immunohistochemical detection of tryptase in small intestine of rats in each group (× 400) Figure 4
Immunohistochemical detection of tryptase in small intestine of rats in each group (× 400). Brownish granules in 
the cytoplasm were recognized as positive staining for tryptase.BMC Gastroenterology 2008, 8:42 http://www.biomedcentral.com/1471-230X/8/42
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Ultrastructure of intestinal mucosal mast cells of rats in each group (× 10,000) Figure 5
Ultrastructure of intestinal mucosal mast cells of rats in each group (× 10,000). There are abundant vacuolus with a 
reduction in granulation in their endochylema in group M and CP; Granulation in endochylema is obvious (Is this right?). There 
is no vacuolus in their endochylema in the sham group. These changes in ultrastructure are ameliorated by treatment with 
Cromolyn Sodium and kotifen in group C and K.BMC Gastroenterology 2008, 8:42 http://www.biomedcentral.com/1471-230X/8/42
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Histological structure of lung of rats in each group (HE Staining, × 200) Figure 6
Histological structure of lung of rats in each group (HE Staining, × 200). The lung histological structure was normal 
in sham-operated group, while the lung tissues were obviously damaged with edema, hemorrhage, and inflammatory cell infil-
tration in group M and CP, and the injury was ameliorated in group C and K.BMC Gastroenterology 2008, 8:42 http://www.biomedcentral.com/1471-230X/8/42
Page 10 of 11
(page number not for citation purposes)
of 75 min and 3 days' reperfusion is appropriate in our
study.
IMMC is an enriched source of inflammatory mediators
such as histamine, prostaglandin D2, leukotriene, IL-3, IL-
4, IL-5, IL-6, IL-8, IL-10, IL-13, IL-16, TNF-α, and more
[11]. Boros and his lab reported that mucosal mast cell de-
granulation plays an important role in the initiation of tis-
sue injury after intestinal ischemia-reperfusion injury, and
depletion of mast cells with compound 48/80 pretreat-
ment prior to ischemia decreased the severity of mucosal
damage [6]. Kalia found the survival rate increased signif-
icantly after ketotifen pretreatment [8]. Andoh A reported
that intestinal ischemia-reperfusion treatment induce a
marked increase in mucosal permeability and IMMC
degranulation, while the mucosal permeability and
IMMC degranulation are significantly attenuated in mast
cell deficient Ws/Ws rats [5]. Our previous study also
proved that IIRI induces IMMC degranulated and the his-
tamine concentration in intestine decreased [12], admin-
istrated cromolyn sodium could attenuate intestinal
damage caused by IIRI [13]. The above studies suggest that
stabilization of mast cells or degranulation of mast cells
prior to ischemia may be a key mechanism to protect the
gastrointestinal tract from injury. However, the studies
about the effects of stabilization or de-granulation of mast
cells after ischemia on IIRI and the survival rate have not
previously been well investigated.
Cromolyn Sodium (CS) is a mast cell membrane stabi-
lizer, it can inhibit the mast cell de-granulation and releas-
ing of histamine, TNF-α, and other inflammatory
mediators [14]. Ketotifen is a second generation hista-
mine H2 blocker which has been used in the management
of allergic disorders. In addition to histamine receptor
antagonism, ketotifen has been found to inhibit the
release of mast cell and neutrophil-derived proinflamma-
tory mediators. Compound 48/80 is a condensation prod-
uct of p-metoxyphenethyl-methylamine and
formaldehyde, and is a potent inducer of mast cell de-
granulation in rats [15]. The dosage of the above drugs
were selected based on previous reports [8,16,17]. We
found the survival rates during the 1st to the 3rd day with
CS and ketotifen treatment were increased significantly
compared with group M, while it decreased significantly
with Compound 48/80 treatment compared with group
M. The results indicate that stabilization of mast cells or
antihistaminic after ischemia can also increase the sur-
vival rates while de-granulation of mast cells after
ischemia can decrease the survival rates.
We observed functional changes in multi-organs in the
survival rats, and analyzed the reasons that caused the rats
to die as the dead animals couldn't be analyzed. Reper-
fusion with oxygenated blood after sustained ischemia is
necessary to recover normal tissue and organ function.
Intestinal mucosa is one of the best recovered organs in 24
hours after IIRI [18]. We also found there were no signifi-
cant differences in Chiu's score among the five groups on
the 3rd day in the survival rats. The results also demon-
strated that intestinal mucosa can be easily recovered from
IIRI, which may the main reason that explains why the
mortality didn't increase after the 3rd day.
Surprisingly, we found that IMMC counts were the same
in the survival rats in the five groups. Although there were
abundant vacuoles with reduced numbers of granules in
their endochylema after treatment with compound 48/80,
and there were fewer swollen granules in IMMC homoge-
neity after treatment with CS or ketotifen. The results
prove that compound 48/80 induces IMMC degranula-
tion while CS and ketotifen inhibited IMMC degranula-
tion. The findings indicated that inhibited IMMC from de-
granulation may increase the survival rates after IIRI.
Previous studies have shown the important role of TNF-α,
IL-1β and IL-6 for reperfusion-induced tissue injury and
lethality [19]. IL-10 has anti-inflammatory properties and
reduces tissue inflammatory injury following ischemia
and reperfusion injury [20]. Our study found that the
level of IL-6 in intestine in group model increases signifi-
cantly compared with group sham on the third day, while
the level of IL-10 in intestine decreased significantly on
the 3rd day. Treatment with cromolyn sodium and keto-
tifen can decrease the levels of TNF-α and IL-6 in intestinal
significantly compared with group model. The results
indicates that CS and ketotifen can also decrease inflam-
mation after IIRI, which may be another reason for the
increased survival rates after treatment with CS and keto-
tifen.
ALT is synthesized in cytoplasm and AST is synthesized in
mitochondria. The increased ratio of S/L represents the
severity of liver cell injuries. The increased CK and LDH
reflects damages in myocardial cells peculiarly. TP
respond to nutritional conditions and liver anabolic state.
Our study found that the increased ratios of S/L, LDH and
CK, and the decreased levels of TP in groups M, C and
group K compared to group S in the survival rats. And the
concentrations of AST and CRE increased significantly in
group CP compared with group M. The lung tissues were
obviously damaged with edema, hemorrhage, and
inflammatory cell infiltration in group M and CP, and the
injuries were ameliorated after treatment with CS and
ketotifen. The above results indicates that intestinal
ischemia could not only induce intestinal reperfusion
injury but also induced remote organ injury such as liver,
heart and lung [21-23], and the remote organ injury may
be one of the important reasons that cause the animal to
die.BMC Gastroenterology 2008, 8:42 http://www.biomedcentral.com/1471-230X/8/42
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Conclusion
Intestinal mucosal mast cells play an important role in the
intestinal ischemia-reperfusion injury. Treatment with CS
and ketotifen prior to reperfusion and following reper-
fusion could increase the survival rates on the 3rd day,
while treatment with compound 48/80 could decrease the
survival rates. Inhibition of mast cells from de-granula-
tion provides a new treatment strategy to protect multiple
organ injury induced by intestinal ischemia reperfusion.
(The first 3 days) after ischemia-reperfusion injury is the
most important time period for treatment. However,
inflammatory injury to the intestines and damages to
remote organs 3 days after reperfusion still exist.
Abbreviations
CS: Cromolyn Sdium; CP: Compound 48/80; AST:
glutamic-oxaloacetic transaminase; ALT: glutamic pyruvic
transaminase; S/L: the ratio of AST compare ALT; TP: total
protein; ALB: albumin; GLB: globulin; A/G: the ratio of
ALB compare GLB; CK: phosphocreatine kinase; LDH: lac-
tate dehydrogenase; BUN: urea nitrogen; CRE: creatinine;
IIRI: Intestinal ischemia-reperfusion injury; IMMC: Intes-
tinal mucosal mast cells.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
H-ZQ participated in the conception and design of the
study, and revised the manuscript. G-XL established the
experimental setup, and drafted the manuscript. H-PJ and
W-J carried out biochemical study and carried out patho-
logical examination. S-N and G-WL collected and ana-
lyzed the data. All authors read and approved the final
manuscript.
Acknowledgements
We would like to thank Jia-jun Liu for his help in the experiment.
References
1. Siniscalchi A, Spedicato S, Lauro A, Pinna AD, Cucchetti A, Dazzi A,
Piraccini E, Begliomini B, Braglia V, Serri T, Faenza S: Intraoperative
coagulation evaluation of ischemia-reperfusion injury in
small bowel transplantation: a way to explore.  Transplantation
proceedings 2006, 38(3):820-822.
2. McMonagle MP, Halpenny M, McCarthy A, Mortell A, Manning F, Kilty
C, Mannion D, Wood AE, Corbally MT: Alpha glutathione S-
transferase: a potential marker of ischemia-reperfusion
injury of the intestine after cardiac surgery?  Journal of pediatric
surgery 2006, 41(9):1526-1531.
3. Oldenburg WA, Lau LL, Rodenberg TJ, Edmonds HJ, Burger CD:
Acute mesenteric ischemia: a clinical review.  Arch Intern Med
2004, 164(10):1054-62.
4. Alicia BP, Maria IR, Ramon SP: Role of mast cells in gastrointes-
tinal mucosal defense.  Biocell 2003, 27(2):163-172.
5. Andoh A, Fujiyama Y, Araki Y, Kimura T, Tsujikawa T, Bamba T: Role
of complement activation and mast cell degranulation in the
pathogenesis of rapid intestinal ischemia/reperfusion injury
in rats.  Digestion 2001, 63(Suppl 1):103-107.
6. Boros M, Ordogh B, Kaszaki J, Nagy S: The role of mast cell
degranulation in ischaemia-reperfusion-induced mucosal
injury in the small intestine.  Annals of the Academy of Medicine, Sin-
gapore 1999, 28(1):79-84.
7. Cordeiro PG, Lee JJ, Mastorakos D, Hu QY, Pinto JT, Santamaria E:
Prevention of ischemia-reperfusion injury in a rat skin flap
model: the role of mast cells, cromolyn sodium, and hista-
mine receptor blockade.  Plastic and reconstructive surgery 2000,
105(2):654-659.
8. Kalia N, Brown NJ, Wood RF, Pockley AG: Ketotifen abrogates
local and systemic consequences of rat intestinal ischemia-
reperfusion injury.  Journal of gastroenterology and hepatology 2005,
20(7):1032-1038.
9. Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN: Intestinal
mucosal lesion in low flow states.  Arch Surg 1970,
101(4):478-483.
10. Collard CD, Gelman S: Pathophysiology, clinical manifesta-
tions, and prevention of ischemia-reperfusion injury.  Anesthe-
siology 2001, 94(6):1133-1138.
11. Ott VL, Cambier JC: Activating and inhibitory signaling in mast
cells: new opportunities for therapeutic intervention.  J Allergy
Clin Immunol 2000, 106(3):429-440.
12. Xiao-liang Gan, Zi-qing Hei, He-qing Huang, Li-xin Chen, Shang-rong
Li: Effect of astragalus membranaceus injection on the activ-
ity of the intestinal mucosal mast cells after hemorrhage
shock-reperfusion in rats.  Chin Med J 2006, 119(22):1892-1898.
13. Hei ZQ, Gan XL, Luo GJ, Li SR, Cai J: Pretreatment of cromolyn
sodium prior to reperfusion attenuates early reperfusion
injury after the small intestine ischemia in rats.  World J Gastro-
enterol 2007, 13(38):5139-5146.
14. Hemmati AA, Nazari Z, Motlagh ME, Goldasteh S: The role of
sodium cromolyn in treatment of paraquat-induced pulmo-
nary fibrosis in rat.  Pharmacol Res 2002, 46(3):229-234.
15. Liu S, Hiedayati N, Shudou M, Maeyama K: Activation of connec-
tive tissue-type and mucosal-type mast cells in compound
48/80-induced airway response.  European journal of pharmacology
2006, 530(1–2):128-135.
16. Boros M, Kaszaki J, Ordogh B, Nagy S: Mast cell degranulation
prior to ischemia decreases ischemia-reperfusion injury in
the canine small intestine.  Inflamm Res 1999, 48(4):193-198.
17. Vural KM, Liao H, Oz MC, Pinsky DJ: Effects of mast cell mem-
brane stabilizing agents in a rat lung ischemia-reperfusion
model.  The Annals of thoracic surgery 2000, 69(1):228-232.
18. Chang JX, Chen S, Ma LP, Jiang LY, Chen JW, Chang RM, Wen LQ,
Wu W, Jiang ZP, Huang ZT: Functional and morphological
changes of the gut barrier during the restitution process
after hemorrhagic shock.  World J Gastroenterol 2005,
11(35):5485-91.
19. Spanos CP, Papaconstantinou P, Spanos P, Karamouzis M, Lekkas G,
Papaconstantinou C: The Effect of L: – arginine and Aprotinin
on Intestinal Ischemia-reperfusion Injury.  J Gastrointest Surg
2007, 11(3):247-255.
20. Souza DG, Guabiraba R, Pinho V, Bristow A, Poole S, Teixeira MM:
IL-1-driven endogenous IL-10 production protects against
the systemic and local acute inflammatory response follow-
ing intestinal reperfusion injury.  J Immunol 2003,
170(9):4759-4766.
21. Tian XF, Yao JH, Li YH, Gao HF, Wang ZZ, Yang CM, Zheng SS: Pro-
tective effect of pyrrolidine dithiocarbamate on liver injury
induced by intestinal ischemia-reperfusion in rats.  Hepatobil-
iary Pancreat Dis Int 2006, 5(1):90-95.
22. Hei ZQ, Gan XL, Huang HQ, Luo GJ, Li SR, Cai J: Protective effects
of cromolyn sodium on intestinal ischaemia-reperfusion-
triggered lung injury in rats.  British journal of anaesthesia 2007,
98(3):407-408.
23. Pierro A, Eaton S: Intestinal ischemia reperfusion injury and
multisystem organ failure.  Seminars in pediatric surgery 2004,
13(1):11-17.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-230X/8/42/pre
pub